Sites in the ERG Network work with many communities — the geographic communities within which our clinical research sites are located and the broader communities of all those dedicated to advancing research. We strive to be active participants, using the power of collective effort to accelerate new therapeutic options for those who need them so desperately.
Leading the world in global research, the mission of the ALS Association is to discover treatments and a cure for ALS, and to serve, advocate for and empower people affected by ALS to live their lives to the fullest.
The Rogers-Lowell Area Chamber of Commerce is a nonprofit business and community development organization serving Rogers, Lowell, and all of Northwest Arkansas. They are the Voice of Business in Northwest Arkansas and the Keeper of the Community Vision for the Rogers-Lowell Area.
The STARR Coalition is a nonprofit organization that develops unbiased, collaborative initiatives to reduce the stigma associated with mental health disorders and to promote clinical research as an option for those seeking help. The organization brings together thought leaders from the pharmaceutical industry, contract research organizations, clinical research sites, and patient advocacy groups.
When enrolling psychiatric clinical research studies, patients are rigorously screened for suicidal thoughts—but then are often simply rejected from the study rather than being offered the help they so desperately need. STARR 911 is designed to change this, bridging the gap between clinical research and suicide prevention. The STARR Coalition partnered with ERG to sponsor an onsite training video for research staff, the first step in a comprehensive training program.
The Society for Clinical Research Sites (SCRS) was founded in 2012 to represent clinical research sites globally, providing a unified voice and a community dedicated to greater site sustainability. SCRS currently represents over 9,500 research sites in 47 countries, serving as an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.
The Global Alzheimer’s Platform Foundation (GAP) focuses on reducing the time and cost of Alzheimer’s disease (AD) clinical research trials in order to speed innovative therapies to those who need them. GAP-Net is a key initiative; this network of more than 60 leading academic and private clinical research sites across the United States and Canada fast-tracks patient recruitment and optimizes site operations, accelerating trial start-up. ERG is proud to be part of this network.
ERG is a founding patron of the CNS Summit. This community of leaders from pharmaceutical and biotech companies, innovative technology companies, startups, patient advocates, investigator sites, service companies, regulators and investors is driven to accelerate the success of programs that bring novel treatments to patients.
